| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 06/12/2003 | US20030109700 Antilipemic agents, anticholesterol agents, cardiovascular disorders, antiischemic agents |
| 06/12/2003 | US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds |
| 06/12/2003 | US20030109532 Modulators of dopamine neurotransmission |
| 06/12/2003 | US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 06/12/2003 | US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy |
| 06/12/2003 | US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4. |
| 06/12/2003 | CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 06/11/2003 | EP1318140A1 Novel amide derivatives and medicinal use thereof ugs |
| 06/11/2003 | EP1317490A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 06/11/2003 | EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 06/11/2003 | EP1317431A2 Polyarylcarboxamides useful as lipid lowering agents |
| 06/11/2003 | EP1317411A1 Derivatives of naphthalene with comt inhibiting activity |
| 06/11/2003 | EP1105372B1 Methoximinophenylacetic acid amides |
| 06/11/2003 | EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them |
| 06/11/2003 | CN1423641A Quaternary salts of N-substituted cyclic or acyclic amines as pharmaceuticals |
| 06/10/2003 | US6576684 Ammonium, phosphonium or sulfonium containing oligomers or polymers; controlled molecular weight, low polydispersity and a vinyl or dienyl end group; polymeric precursors and addi-tives |
| 06/10/2003 | US6576672 Parkingson's Disease and dementias characterized by mito-chondrial damage; such as 3,7-diazanonane-1,9-diamine; neutralizing dopamine depriving effect |
| 06/10/2003 | US6576664 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor |
| 06/10/2003 | US6576645 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 06/10/2003 | US6576614 Administering methyl ketones or closed hemiketal derivatives of aspartic acid |
| 06/10/2003 | CA2083505C New use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders |
| 06/10/2003 | CA2055670C Retroviral protease inhibiting compounds |
| 06/10/2003 | CA2040489C 4-¬3-(4-oxothiazoldinyl)|butynylamines, a process for their preparation and their use as medicaments |
| 06/05/2003 | WO2003045928A1 Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors |
| 06/05/2003 | WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 06/05/2003 | WO2003045919A2 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 06/05/2003 | WO2003045393A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma |
| 06/05/2003 | WO2003045306A2 Phenoxy amine compounds and compositions for delivering active agents |
| 06/05/2003 | WO2002048124A3 Piperazine derivatives |
| 06/05/2003 | US20030105161 Analgesics; antiinflamamtory agents |
| 06/05/2003 | US20030105148 Selective estrogen receptor modulators |
| 06/05/2003 | US20030105113 Enantiomers of 1-[ (4-chlorophenyl) phenylmethyl ] -4-[ (4-methylphenyl) sulfonyl ] piperazine |
| 06/05/2003 | US20030105112 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine |
| 06/05/2003 | US20030105107 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 06/05/2003 | US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 06/05/2003 | US20030105099 Novel compounds and compositions as cathepsin inhibitors |
| 06/05/2003 | US20030105094 For therapy of metabolic disorder, an eating disorder or diabetes |
| 06/05/2003 | US20030105091 Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| 06/05/2003 | US20030105079 Novel phenylalkyl diamine and amide analogs |
| 06/05/2003 | US20030105066 For use in producing antiviral, antifungal and antibacterial medicaments |
| 06/05/2003 | CA2468716A1 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 06/05/2003 | CA2467966A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma |
| 06/05/2003 | CA2464107A1 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 06/04/2003 | EP1315494A1 Agent for modulating excitatory synaptic transmission comprising a compound having alpha-7 nicotinic acetylcholine receptor activation property |
| 06/04/2003 | EP0966439B1 Certain cyclic thio substituted acylaminoacid amide derivatives |
| 06/04/2003 | CN1422266A Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 06/04/2003 | CN1422263A Estrogen agonist/antagonist metabolites |
| 06/04/2003 | CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 06/04/2003 | CN1422254A Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 06/04/2003 | CN1422251A Novel alpha-sulfin-and alpha-sulfonamino acid amide derivatives |
| 06/04/2003 | CN1422250A Alpha-sulfin-and alpha-sulfonamino acid amide derivatives |
| 06/03/2003 | USRE38133 Kappa agonist compounds and pharmaceutical formulations thereof |
| 06/03/2003 | US6573395 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine)) |
| 06/03/2003 | US6573297 (2-substituted oxyphenyl)alkanamide derivative, hair growth promoter and external composition for skin using the same |
| 06/03/2003 | US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 06/03/2003 | US6573266 Piperazine derivatives and their use as anti-inflammatory agents |
| 06/03/2003 | US6573264 Heteroaryl alkyl piperazine derivatives |
| 05/30/2003 | WO2003044031A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them |
| 05/30/2003 | WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease |
| 05/30/2003 | WO2002088100A3 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 05/30/2003 | WO2002042284A1 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 05/30/2003 | WO2002031025A9 Biodegradable poly(beta-amino esters) and uses thereof |
| 05/30/2003 | CA2467476A1 Amino diols useful in the treatment of alzheimer's disease |
| 05/30/2003 | CA2429539A1 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 05/29/2003 | US20030100754 Naphthalene compounds, intermediates, formulations, and methods |
| 05/29/2003 | US20030100750 Process for solid supported synthesis of pyruvate-derived compounds |
| 05/29/2003 | US20030100608 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 05/29/2003 | US20030100580 Benzenesulfonamide derivatives; for treatment of cardiovascular disorders |
| 05/29/2003 | US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 05/29/2003 | US20030100548 Antiarthritic agents; atherosclerosis and chronic obstructive pulmonary disease treatments |
| 05/28/2003 | EP1314721A1 Novel propenohydroxamic acid derivatives |
| 05/28/2003 | EP1314712A1 Nf-kappa-b inhibitor containing substituted benzoic acid derivative as active ingredient |
| 05/28/2003 | EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 05/28/2003 | EP1313720A1 N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide |
| 05/28/2003 | EP1313700A1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds |
| 05/28/2003 | EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 05/28/2003 | EP1313560A1 CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION |
| 05/28/2003 | EP1169300B1 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof |
| 05/28/2003 | EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 05/28/2003 | EP0850222B1 Piperazine derivatives and process for the preparation thereof |
| 05/28/2003 | EP0814792B1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 05/28/2003 | EP0788360B1 Boronic ester and acid compounds, synthesis and uses |
| 05/28/2003 | CN1420870A Modulators of dopamine neurotransmission |
| 05/28/2003 | CN1420869A Modulators of dopamine neurotransmission |
| 05/28/2003 | CN1109677C Monohydrates of aminobenzenesulfonic acid derivs. and method for preparing same |
| 05/27/2003 | US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors |
| 05/27/2003 | US6570016 Process for preparing a 10,11-methanodibenzosuberane derivative |
| 05/27/2003 | US6569882 Viricides; enzyme inhibitors |
| 05/27/2003 | US6569861 Melanin concentrating hormone receptor ligands |
| 05/27/2003 | CA2268847C Substituted oximes derivatives useful as neurokinin antagonists |
| 05/22/2003 | WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 05/22/2003 | WO2003042186A1 Dithiocarbamate derivatives and their use as antibacterial agents |
| 05/22/2003 | WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 05/22/2003 | WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors |
| 05/22/2003 | WO2002095393A3 Drug evolution: drug design at hot spots |
| 05/22/2003 | WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 05/22/2003 | WO1999065864A3 Geminally substituted amines |
| 05/22/2003 | US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists |
| 05/22/2003 | US20030096864 Compounds to treat alzheimer's disease |
| 05/22/2003 | US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite |